Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.90 USD | -1.10% |
|
+4.79% | -38.10% |
| Market Cap | 733M 642M 594M 546M 1.03B 70.66B 1.05B 7.1B 2.78B 34.57B 2.75B 2.69B 119B | P/E 2026 * |
-17.1x | P/E 2027 * | -25.3x |
|---|---|---|---|---|---|
| Enterprise Value | 733M 642M 594M 546M 1.03B 70.66B 1.05B 7.1B 2.78B 34.57B 2.75B 2.69B 119B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.87x |
| Free-Float |
97.27% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Castle Biosciences, Inc.
| 1 day | -0.04% | ||
| 1 week | +4.79% | ||
| Current month | +0.96% | ||
| 1 month | +13.58% | ||
| 3 months | -4.29% | ||
| 6 months | -41.07% | ||
| Current year | -38.10% |
| 1 week | 22.61 |  | 25.13 |
| 1 month | 20.64 | | 25.13 |
| Current year | 17.72 | | 44.28 |
| 1 year | 14.59 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 78.58 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 31/08/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 30/11/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 31/08/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 31/08/2014 |
G. Cole
BRD | Director/Board Member | 70 | 05/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/07/26 | Fiscal year | Founder | 5,272 | 0.0174% | ||
| 01/07/26 | Fiscal year | Founder | 22,264 | 0.0734% | ||
| 01/07/26 | Sell | Chief Operating Officer | -8,586 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.10% | +4.79% | +44.02% | +44.19% | 733M | |
| -5.00% | -5.04% | +229.56% | +303.14% | 20.67B | |
| -1.10% | +3.44% | -39.02% | -23.29% | 9.85B | |
| -2.96% | +1.15% | +48.97% | +25.52% | 7B | |
| -1.19% | +3.84% | +275.87% | -25.85% | 5.55B | |
| +3.43% | +7.18% | -14.36% | -20.83% | 5.23B | |
| -8.46% | +23.30% | +84.85% | +105.62% | 4.9B | |
| -5.64% | -6.04% | -43.34% | - | 4.66B | |
| +1.27% | +2.01% | -22.43% | -25.26% | 4.2B | |
| +1.21% | +5.98% | -14.81% | -39.11% | 2.72B | |
| Average | -1.19% | +3.10% | +54.93% | +38.24% | 6.55B | |
| Weighted average by Cap. | -1.87% | +1.06% | +95.70% | +103.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 352M 309M 285M 263M 495M 33.97B 503M 3.41B 1.34B 16.62B 1.32B 1.29B 57.27B | 393M 344M 318M 293M 552M 37.89B 561M 3.81B 1.49B 18.54B 1.48B 1.44B 63.87B |
| Net income | -43.46M -38.1M -35.21M -32.39M -61.11M -4.19B -62.09M -421M -165M -2.05B -163M -160M -7.07B | -26.06M -22.84M -21.11M -19.42M -36.63M -2.51B -37.22M -252M -98.95M -1.23B -97.84M -95.71M -4.24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$23.90 | -1.10% | 315,668 |
| 17/07/26 | US$24.16 | -0.29% | 242,886 |
| 16/07/26 | US$24.23 | +0.87% | 375,696 |
| 15/07/26 | US$24.02 | +3.89% | 188,232 |
| 14/07/26 | US$23.12 | +0.61% | 251,257 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
